Wealthcreatures.com
1.42K subscribers
1.19K photos
48 videos
40 files
1.54K links
Visit us at www.wealthcreatures.com

Driven by Fundamentals and Leveraging Technicals.

All post are Only For Study & Educational Purpose.consult you Financial Advisor Before Investing or taking any position.
DISCLAIMER:We r Not SEBI REGISTERED ANALYST.
Download Telegram
Wealthcreatures.com
GLAND PHARMA NEW 52WK HIGH BLASTING 7% ๐Ÿ’ฃ๐Ÿ’ฃ 2611 2100 TO 2600++ TILL NOW EXPECTING # 2750/3000++ LONGTERM # 4500+++
GLAND PHARMA:

Q4 NET PROFIT 2.6B RUPEES VS 1.95B (YOY); EST 2.2B | 2.04B (QOQ)

Q4 REVENUE 8.88B RUPEES VS 6.35B (YOY)

Q4 EBITDA 3.75B RUPEES VS 2.86B (YOY)

Q4 EBITDA MARGIN 40% VS 42% (YOY)
Wealthcreatures.com
CYIENT NEW 52WK WEEK HIGH 638 AS EXPEXTED 600++ NOW POSSIBLE SOME COOL OFF TILL 580/555 THAN AGAIN UPMOVE CSN START NEW TEST LEVELS # 666/700/750++
CYIENT

OUR CONVICTION PICK

NEW 52WK HIGH

PAISA DOUBLE

379 TO 810
๐ŸŽฏ๐ŸŽฏ

1000++ coming ๐Ÿ”œ๐Ÿ”œ
CLSA on IT: Our channel checks and conversations with Indian IT companies across scale indicate the second wave of Covid-19 has had a limited impact on project delivery and deal ramp-up so far
AARTI IND # Board Meeting Today on BONUS ISSUE & Results
AARTI IND: Board Approves 1:1 Bonus Issue.Record date will be announced soon

AARTI IND Q4 : Net Profit Up 23 % to Rs 136 cr (YOY)

Revenue Up 12 % to Rs 1209 cr

Recommends Rs 3 as final Dividend
Wealthcreatures.com
ONE OF BEST CHEMICAL STOCK TO ADD ON DIPS ๐Ÿ…ฐARTI INDS CMP - 869 AGRESSIVE PLAYERS START ADDING EVEN FROM CMP AND ON ALL DIPS SAFE PLAYERS ACCMULATION ZONE - 750 TO 850 ADD IN SIP ONLY FOR INVESTMENT FOR 30% TO 40% CAGR RETURNS FOR NEXT 2 TO 5 YEARS
AARTI INDS

Our portfolio pick

Already 2x

GETTING READY FOR 4ร—/5ร— IN NEXT 5 years

GREAT VISION#

Massive CAPEX OF
4500-5000cr over FY22-24 to drive growth beyond FY25!

1500 Crores of CAPEX to be commercialized by FY23!

Co wants to almost double the EBITDA over next 3 years!

1 Lac crore market cap by 2027